The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search ... cancer products from Seagen it ...

There is currently no licensed vaccine for norovirus – commonly known as the winter vomiting bug – but are scientists getting ...

The survey, conducted in September by pharmaceutical giant Moderna in collaboration with data platform Dynata, gathered ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

Among the latter: “major, major changes in the way the FDA regulates the pharmaceutical industry,” says the regulatory ... in ...

Arbutus has moved into Part 3 of this clinical trial which evaluates repeat dosing of AB-101 for 28 days in patients with cHBV and expects to report preliminary data in the first half of next year.

December S&P 500 E-Mini futures (ESZ24) are up +0.27%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.33% this morning, extending their post-Election Day gains, while investors looked ahead ...

The intersection of sports marketing and the pharmaceutical industry offers a dynamic space where brands can leverage ...

we'll continue to deploy the strain engineering, high-throughput screening and process development capabilities, as well as ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress toward potential commerciali ...

Charlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ...